We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Augean Plc | LSE:AUG | London | Ordinary Share | GB00B02H2F76 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 371.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMAUG
RNS Number : 2567B
Augean Plc
05 October 2015
Augean plc
("Augean" or "the Group")
Directors Dealing
Augean was informed on 5 October 2015 that, on 2 October 2015, Dr. Stewart Davies, Chief Executive Officer, purchased 50,000 ordinary shares of 10p each ("Ordinary Shares") at a price of 54.5 pence per share.
Accordingly, Dr. Stewart Davies has a beneficial interest in 155,000 Ordinary Shares representing 0.15% of the current issued share capital and total voting rights of the Company.
-Ends-
For further information, call:
Augean plc Dr Stewart Davies, Chief Executive Richard Laker, Group Finance Director 01937 844 980 N+1 Singer Shaun Dobson Richard Lindley Jennifer Boorer 020 7496 3000 FTI Consulting Oliver Winters Adam Cubbage 020 3727 1000
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSDMMGGZKMGKZM
(END) Dow Jones Newswires
October 05, 2015 08:43 ET (12:43 GMT)
1 Year Augean Chart |
1 Month Augean Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions